Talk:Paromomycin

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
???	This article has not yet received a rating on the project's importance scale.

Medicine C‑class Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
C	This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Paromomycin.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Wiki Education Foundation-supported course assignment

This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Lisablle, Kylie.mitchell, Theo.Ndatimana, KarenLR Pharm. Peer reviewers: Jcua28, Mlmtabs, Kbrown18.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 06:09, 17 January 2022 (UTC)[reply]

comment

Unfortumon the substance pictured is NOT a sulfate, It appears to be Paromomycin and the structure is not good, the B ring of the paromomycin do not contains oxygen, it is 6 cycle with only carbon. ```` —Preceding unsigned comment added by Jester mclarpet (talk • contribs) 19:49, 9 May 2009 (UTC)[reply]

Not paromomycin

Come on, this is not paromomycin the B ring is not an hetero cycle, go see neomycin and you'll see that this picture is wrong.See https://www.scbt.com/scbt/product/paromomycin-sulfate-1263-89-4 — Preceding unsigned comment added by 132.204.72.52 (talk) 20:08, 20 June 2011 (UTC)[reply]

Thx mate, I have removed the wrong O atom. Cheers, --Yikrazuul (talk) 17:01, 21 June 2011 (UTC)[reply]

The paromomycine bind to the 30S ribosome sub-unit. — Preceding unsigned comment added by 132.204.67.218 (talk) 14:50, 3 November 2011 (UTC)[reply]

Conflation of data about Paromomycin and Paromomycin Sulfate in the Drug infobox

It looks like the redirect of the record has only been partially reflected in the data in the Drug infobox . Several fields including the CSID and InChI/InChIKey relate to the sulfate salt - can we have some clarification on which species is featured in the Drug infobox??? --The chemistds (talk) 15:35, 1 April 2014 (UTC)[reply]

Words as Power - Expanding WikiProject Pharmacology

Kbrown18, Mlmtabs, NedaNassr, and Jcua28 will review the page accordingly:

STUDENT 1 – Does the draft submission reflect a neutral point of view? If not, specify…

- Overall the draft does reflect a neutral point of view, but some attention needs to be given under medical uses since a part of it is copied word for word from an online article. In addition, it says that the cream is effective due to a trial, but the trial is not a secondary source to begin with and should be changed. Please review student 4's recommendations for more information. Also, please review student 2's recommendations since some of the citations seem to be primary sources which need to be changed since most people do not have access to these sources. NedaNassr (talk) 22:48, 14 November 2016 (UTC)[reply]

STUDENT 2 – Are the points included verifiable with cited secondary sources that are freely accessible? If not, specify…

- Please review reference numbers 1, 7, 8, 20, and 22 as they appear to be primary literature. Reference number 17, although a tertiary resource, is not easily accessible by the public and should be excluded. Under Pregnancy and breastfeeding, please find appropriate citation for pregnancy category. Jcua28 (talk) 09:12, 14 November 2016 (UTC)[reply]

STUDENT 3 – Are the edits formatted consistent with Wikipedia’s manual of style for medicine-related articles? If not, specify…

- Please review and remove the last sentence of Medical Uses of gentamycin and paromomycin. It reports uses due to a primary source of a specific study and does not meet the tertiary/neutral source required by Wikipedia Medicine-related articles.

- Please review Adverse Effects and avoid suggesting specific advice for patient consultation education.

- Please review use of medical terminology wording throughout the drug article and particularly in the Interactions section that do not contain lay language for the general public. Words such as concurrent and nephrotoxicity can easily be replaced with words that are familiar to those who do not possess a medical background. Kbrown18 (talk) 01:42, 15 November 2016 (UTC)[reply]

STUDENT 4 – Is there any evidence of plagiarism or copyright violation? If yes, specify…

- Please review under Mechanism section: "This broad-spectrum antibiotic soluble in water, is very similar in action to neomycin." It is almost identical to the source's description of the drug. I would suggest rewording phrase as well as maybe adding in how/what specific part of action is similar to neomycin. Mlmtabs (talk) 20:59, 14 November 2016 (UTC)[reply]

- Please review under Medical Uses: " Paromomycin topical cream with or without gentamicin is an effective treatment for ulcerative cutaneous leishmaniasis, according to the results of a phase-3, randomized, double-blind, parallel group–controlled trial.[8]" It is identical to the first sentence found on this article about the same trial http://www.medscape.com/viewarticle/778974. Mlmtabs (talk) 20:54, 14 November 2016 (UTC)[reply]

Jcua28 (talk) 09:00, 14 November 2016 (UTC)[reply]